Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3VJD

Crystal structure of the Y248A mutant of C(30) carotenoid dehydrosqualene synthase from Staphylococcus aureus

Summary for 3VJD
Entry DOI10.2210/pdb3vjd/pdb
Related2ZCO 2ZCP 2ZCQ 2ZCR 2ZCS 2ZY1 3VJE
DescriptorDehydrosqualene synthase, L(+)-TARTARIC ACID (3 entities in total)
Functional Keywordscrtm, carotenoid biosynthesis, staphyloxanthin biosynthesis, transferase, head-to-head condensation
Biological sourceStaphylococcus aureus
Total number of polymer chains1
Total formula weight34845.49
Authors
Liu, C.I.,Jeng, W.Y.,Chang, W.J.,Wang, A.H.J. (deposition date: 2011-10-14, release date: 2012-04-11, Last modification date: 2023-11-08)
Primary citationLiu, C.I.,Jeng, W.Y.,Chang, W.J.,Ko, T.P.,Wang, A.H.J.
Binding modes of zaragozic acid A to human squalene synthase and staphylococcal dehydrosqualene synthase
J.Biol.Chem., 287:18750-18757, 2012
Cited by
PubMed Abstract: Zaragozic acids (ZAs) belong to a family of fungal metabolites with nanomolar inhibitory activity toward squalene synthase (SQS). The enzyme catalyzes the committed step of sterol synthesis and has attracted attention as a potential target for antilipogenic and antiinfective therapies. Here, we have determined the structure of ZA-A complexed with human SQS. ZA-A binding induces a local conformational change in the substrate binding site, and its C-6 acyl group also extends over to the cofactor binding cavity. In addition, ZA-A effectively inhibits a homologous bacterial enzyme, dehydrosqualene synthase (CrtM), which synthesizes the precursor of staphyloxanthin in Staphylococcus aureus to cope with oxidative stress. Size reduction at Tyr(248) in CrtM further increases the ZA-A binding affinity, and it reveals a similar overall inhibitor binding mode to that of human SQS/ZA-A except for the C-6 acyl group. These structures pave the way for further improving selectivity and development of a new generation of anticholesterolemic and antimicrobial inhibitors.
PubMed: 22474324
DOI: 10.1074/jbc.M112.351254
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.48 Å)
Structure validation

236371

数据于2025-05-21公开中

PDB statisticsPDBj update infoContact PDBjnumon